Skip to main content
Jianmin Pharmaceutical Group Co., Ltd. logo

Jianmin Pharmaceutical Group Co., Ltd. — Investor Relations & Filings

Ticker · 600976 ISIN · CNE000001HB7 Shanghai Stock Exchange Manufacturing
Open in API
Filings indexed 1,559 across all filing types
Latest filing 2025-07-14 AGM Information
Country CN China
Listing Shanghai Stock Exchange 600976

About Jianmin Pharmaceutical Group Co., Ltd.

https://www.whjm.com/

Jianmin Pharmaceutical Group Co., Ltd. is a specialized pharmaceutical enterprise with a heritage dating back to 1637. The company focuses on the research, development, and manufacturing of Traditional Chinese Medicine (TCM) and modern healthcare products. Its core portfolio emphasizes pediatric health, gynecological treatments, and chronic disease management. Key products include Longmu Zhuanggu Granules, recognized for supporting bone development and overall health in children. The group integrates traditional pharmacological wisdom with contemporary biotechnology and standardized production processes. Jianmin Group operates through a comprehensive value chain encompassing raw material sourcing, advanced manufacturing, and a distribution network. By leveraging its status as a time-honored brand, the company maintains a strong market position in the pediatric TCM segment while expanding its presence in general wellness and prescription drug markets.

Recent filings

Filing Released Lang Actions
健民集团2025年第一次临时股东大会通知
AGM Information Classification · 95% confidence The document is a detailed notice about the convening of the 2025 first extraordinary general meeting (临时股东大会) of shareholders for 健民药业集团股份有限公司. It includes information about the meeting date, voting methods (including cumulative voting for board elections), agenda items such as amendments to company bylaws, election of directors and independent directors, and procedural details for shareholders to attend and vote. There is no financial data or financial results presented, nor is this a transcript or presentation. The document is not an announcement of voting results but a notice of the meeting itself. This fits the definition of AGM Information (AGM-R), which covers presentations and materials shared during the Annual General Meeting or other shareholder meetings. The document length is about 4895 characters, which is sufficient for a full notice rather than a brief announcement. Therefore, the classification is AGM-R with high confidence.
2025-07-14 Chinese
健民药业集团股份有限公司独立董事候选人声明
Board/Management Information Classification · 95% confidence The document consists of declarations by independent director candidates of a company, detailing their qualifications, independence, and compliance with relevant laws and regulations. It is a formal statement confirming their eligibility and commitment to serve as independent directors. There is no financial data, no report or results, no meeting materials, no voting results, and no regulatory filings per se. This type of document is typically related to board or management information, specifically announcements about changes or nominations in the company's board of directors. Therefore, the document fits best under the category of Board/Management Information (MANG). The document length is 4148 characters, which is consistent with a detailed declaration rather than a brief announcement or a full report.
2025-07-14 Chinese
健民集团关于开展资产池业务的公告
Capital/Financing Update Classification · 95% confidence The document is a detailed announcement from 健民药业集团股份有限公司 regarding the company's plan to continue an asset pool business with a bank, including credit limits, guarantees, risk controls, and approvals. It includes financial data, descriptions of agreements, and corporate governance procedures related to this financing activity. The document is not a full financial report like an Annual Report (10-K) or Interim Report (IR), nor is it a simple announcement of a report publication. It is a specific update on financing activities involving credit facilities and guarantees, which fits the definition of a Capital/Financing Update (CAP).
2025-07-14 Chinese
健民集团关于修订《公司章程》及相关制度的公告
Governance Information Classification · 95% confidence The document is an announcement from the board of directors of 健民药业集团股份有限公司 regarding proposed amendments to the company's Articles of Association (公司章程) and related governance documents. It details the main changes to the Articles, such as removal of the supervisory board, enhancements to shareholder and board provisions, and updates to internal governance rules. The document also mentions that these amendments require shareholder approval at a general meeting. The text is regulatory in nature, announcing governance changes and procedural steps, but does not contain financial statements or detailed financial data. It is not a full annual or interim report, nor an earnings release or audit report. It is not a proxy solicitation or voting results announcement, but rather a governance-related announcement about changes to the company's internal rules and governance documents. Therefore, the best fitting category is Governance Information (CGR). The document length is under 5,000 characters and it is a detailed announcement, not just a brief notice or report publication announcement.
2025-07-14 Chinese
健民集团第十届董事会第三十七次会议决议公告
Board/Management Information Classification · 95% confidence The document is a detailed announcement of resolutions passed at the 37th meeting of the 10th Board of Directors of the company, including nominations for the next board, amendments to company bylaws, and plans for an upcoming extraordinary general meeting. It includes voting results and references to further announcements on the stock exchange website. The content focuses on board and management decisions and nominations rather than financial results or reports. The document length is about 2794 characters, which is relatively short and typical for a board meeting resolution announcement. Therefore, this document fits best under the category of Board/Management Information (MANG).
2025-07-14 Chinese
健民药业集团股份有限公司章程修订对照表
Governance Information Classification · 100% confidence The document is a detailed and extensive text primarily consisting of amendments and revisions to the company's articles of association (章程修订对照表). It includes detailed provisions about the company's governance structure, board of directors, shareholders' rights, audit committee, independent directors, and other corporate governance matters. There is no indication of financial statements, audit opinions, earnings data, or other financial performance information. The content focuses on governance rules, board responsibilities, shareholder meetings, and related corporate governance topics. Therefore, this document fits best into the category of Governance Information (CGR), which covers reports detailing the company's internal rules, board structure, and governance practices.
2025-07-14 Chinese

Browse filings by year

23 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.